All doses of the diabetes and weight management injectable tirzepatide (Mounjaro, Zepbound) were taken off the FDA's shortage ...

With an estimated 2 million people in the United States taking copycat vers | A compounding industry group has sued the FDA, ...

A trade organization representing compounding pharmacies that make unbranded versions of the weight loss drugs Mounjaro and ...

FDA faces legal action after removing Tirzepatide from the shortage list without following required procedures, sparking ...

Now that Mounjaro has been authorised for use on the NHS, it will be key that access to specialist weight loss services is ...

Starboard has a roughly $1 billion stake in the drugmaker and approached former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio ...

A group representing makers of compounded drugs sued FDA over its decision to call an end to the shortage of Lilly's (LLY) ...

The Outsourcing Facilities Association (OFA) has filed a lawsuit against the U.S. Food and Drug Administration (FDA) regarding the agency’s sudden removal of Tirzepatide, a GLP-1 medication used to ...

McDonald's is suing major meatpackers for allegedly colluding to inflate beef prices by limiting supplies since 2015. PepsiCo ...

WeightWatchers said on Tuesday it would offer a compounded version of Novo Nordisk's popular obesity drug Wegovy as part of ...

On October 2, 2024, the U.S. Food and Drug Administration (FDA) determined the shortage of the tirzepatide injection, a glucagon-like peptide ...

While artificial intelligence (AI) has been one of the hottest investing trends, GLP-1 weight loss drugs are a close second.